U.S. markets closed
  • S&P 500

    4,246.59
    -8.56 (-0.20%)
     
  • Dow 30

    34,299.33
    -94.42 (-0.27%)
     
  • Nasdaq

    14,072.86
    -101.29 (-0.71%)
     
  • Russell 2000

    2,320.07
    -6.07 (-0.26%)
     
  • Crude Oil

    72.44
    +0.32 (+0.44%)
     
  • Gold

    1,860.80
    +4.40 (+0.24%)
     
  • Silver

    27.79
    +0.10 (+0.35%)
     
  • EUR/USD

    1.2130
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    1.4990
    -0.0020 (-0.13%)
     
  • GBP/USD

    1.4083
    -0.0025 (-0.17%)
     
  • USD/JPY

    110.0700
    +0.0090 (+0.01%)
     
  • BTC-USD

    40,159.15
    -31.28 (-0.08%)
     
  • CMC Crypto 200

    995.03
    -15.57 (-1.54%)
     
  • FTSE 100

    7,172.48
    +25.80 (+0.36%)
     
  • Nikkei 225

    29,441.30
    +279.50 (+0.96%)
     

Is It Too Late to Buy AbbVie Stock in 2021?

·4 min read
Is It Too Late to Buy AbbVie Stock in 2021?
  • Oops!
    Something went wrong.
    Please try again later.

AbbVie (NYSE: ABBV) is one of the newer pharmaceutical companies to take the market by storm. The stock has still about 5% off its all-time highs from 2018, and if AbbVie's recent first-quarter earnings tell us anything, it's that the stock can go even higher. AbbVie reported its first-quarter earnings last week, and beat analyst estimates on most metrics.